Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1997 Jul-Sep;3(3):385–389. doi: 10.3201/eid0303.970320

Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.

E J van der Wouden 1, A A van Zwet 1, G D Vosmaer 1, J A Oom 1, A de Jong 1, J H Kleibeuker 1
PMCID: PMC2627643  PMID: 9284388

Abstract

The prevalence of primary metronidazole resistance of Helicobacter pylori was studied in one Dutch hospital from 1993 to 1996 and in two additional Dutch hospitals in 1993 and 1996. All cultures of antral biopsy specimens yielding H. pylori in the study period were evaluated, except those from patients who had received anti-H. pylori treatment; 1,037 H. pylori strains, all from different patients were included. Metronidazole resistance was determined by disk diffusion in 1993 and by Epilipsometer-test in 1994 to 1996. Metronidazole resistance increased from 7% (18/245) in 1993 to 32% (161/509) in 1996. More patients with nonulcer dyspepsia and more non-Western European patients were seen in 1996 than in 1993, but age and sex differences were not observed. A comparable increase in metronidazole resistance was observed in both nonulcer dyspepsia patients and peptic ulcer patients, and the prevalence of metronidazole resistance in Western Europeans increased from 5% in 1993 to 28% in 1996.

Full Text

The Full Text of this article is available as a PDF (26.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banatvala N., Davies G. R., Abdi Y., Clements L., Rampton D. S., Hardie J. M., Feldman R. A. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut. 1994 Nov;35(11):1562–1566. doi: 10.1136/gut.35.11.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Becx M. C., Janssen A. J., Clasener H. A., de Koning R. W. Metronidazole-resistant Helicobacter pylori. Lancet. 1990 Mar 3;335(8688):539–540. doi: 10.1016/0140-6736(90)90772-w. [DOI] [PubMed] [Google Scholar]
  3. Bell G. D., Powell K., Burridge S. M., Pallecaros A., Jones P. H., Gant P. W., Harrison G., Trowell J. E. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther. 1992 Aug;6(4):427–435. doi: 10.1111/j.1365-2036.1992.tb00556.x. [DOI] [PubMed] [Google Scholar]
  4. Berger S. A., Gorea A., Moskowitz M., Santo M., Gilat T. Effect of inoculum size on antimicrobial susceptibility of Helicobacter pylori. Eur J Clin Microbiol Infect Dis. 1993 Oct;12(10):782–783. doi: 10.1007/BF02098470. [DOI] [PubMed] [Google Scholar]
  5. Ching C. K., Leung K. P., Yung R. W., Lam S. K., Wong B. C., Lai K. C., Lai C. L. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut. 1996 May;38(5):675–678. doi: 10.1136/gut.38.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DeCross A. J., Marshall B. J., McCallum R. W., Hoffman S. R., Barrett L. J., Guerrant R. L. Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol. 1993 Aug;31(8):1971–1974. doi: 10.1128/jcm.31.8.1971-1974.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glupczynski Y., Burette A., De Koster E., Nyst J. F., Deltenre M., Cadranel S., Bourdeaux L., De Vos D. Metronidazole resistance in Helicobacter pylori. Lancet. 1990 Apr 21;335(8695):976–977. doi: 10.1016/0140-6736(90)91043-a. [DOI] [PubMed] [Google Scholar]
  8. Graham D. Y., Börsch G. M. The who's and when's of therapy for Helicobacter pylori. Am J Gastroenterol. 1990 Dec;85(12):1552–1555. [PubMed] [Google Scholar]
  9. Hirschl A. M., Hirschl M. M., Rotter M. L. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrob Chemother. 1993 Jul;32(1):45–49. doi: 10.1093/jac/32.1.45. [DOI] [PubMed] [Google Scholar]
  10. Ling T. K., Cheng A. F., Sung J. J., Yiu P. Y., Chung S. S. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter. 1996 Mar;1(1):57–61. doi: 10.1111/j.1523-5378.1996.tb00009.x. [DOI] [PubMed] [Google Scholar]
  11. Midolo P. D., Turnidge J., Lambert J. R., Bell J. M. Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori. Diagn Microbiol Infect Dis. 1995 Mar;21(3):135–140. doi: 10.1016/0732-8893(95)00066-j. [DOI] [PubMed] [Google Scholar]
  12. Mégraud F. Epidemiology of Helicobacter pylori infection: where are we in 1995? Eur J Gastroenterol Hepatol. 1995 Apr;7(4):292–295. [PubMed] [Google Scholar]
  13. Rautelin H., Seppälä K., Renkonen O. V., Vainio U., Kosunen T. U. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother. 1992 Jan;36(1):163–166. doi: 10.1128/aac.36.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Thijs J. C., Van Zwet A. A., Oey H. B. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol. 1993 Nov;28(11):934–938. doi: 10.3109/00365529309098287. [DOI] [PubMed] [Google Scholar]
  15. Thijs J. C., Van Zwet A. A., Thijs W. J., Van der Wouden E. J., Kooy A. One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance. Aliment Pharmacol Ther. 1997 Apr;11(2):305–309. doi: 10.1046/j.1365-2036.1997.155329000.x. [DOI] [PubMed] [Google Scholar]
  16. Walt R. P. Metronidazole-resistant H pylori--of questionable clinical importance. Lancet. 1996 Aug 24;348(9026):489–490. doi: 10.1016/s0140-6736(05)64665-x. [DOI] [PubMed] [Google Scholar]
  17. Weil J., Bell G. D., Powell K., Jobson R., Trowell J. E., Gant P., Jones P. H. Helicobacter pylori and metronidazole resistance. Lancet. 1990 Dec 8;336(8728):1445–1445. doi: 10.1016/0140-6736(90)93145-f. [DOI] [PubMed] [Google Scholar]
  18. van Zwet A. A., Thijs J. C., Roosendaal R., Kuipers E. J., Peña S., de Graaff J. Practical diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1996 May;8(5):501–507. [PubMed] [Google Scholar]
  19. van Zwet A. A., de Boer W. A., Schneeberger P. M., Weel J., Jansz A. R., Thijs J. C. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands. Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):861–864. doi: 10.1007/BF01691216. [DOI] [PubMed] [Google Scholar]
  20. van der Hulst R. W., Keller J. J., Rauws E. A., Tytgat G. N. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter. 1996 Mar;1(1):6–19. doi: 10.1111/j.1523-5378.1996.tb00003.x. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES